drugset / Trial / NCT00116298
Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare long-term safety and tolerability of stavudine (d4T) extended release (ER) versus conventional (immediate release \[IR\]) formulations, each in combination with lamivudine (3TC) and efavirenz (EFV) in subjects who have completed Bristol-Myers Squibb (BMS) studies AI455-096 and AI455-099.
Timeline
- Start
- 2001-01
- Primary completion
- 2005-01
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stavudine | Other / unclassified | — | — |
| Background | Efavirenz | Other / unclassified | — | — |
| Background | Lamivudine | Other / unclassified | — | — |